GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer [Yahoo! Finance]
Gamida Cell Ltd. - Ordinary Shares (GMDA)
Last gamida cell ltd. - ordinary shares earnings: 11/13 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
amino acid alphabet and deliver on the promise of protein therapeutics, today announced the expansion of its leadership with the hire of Tracey Lodie, PhD as Chief Development Officer. Dr. Lodie has more than 20 years of experience in the biopharmaceutical industry focused on the discovery and development of novel biologics and cell therapies in the areas of autoimmunity, transplant biology, and immuno-oncology. Her experience ranges from early drug development through commercialization. Dr. Lodie most recently worked as Chief Scientific Officer at Quell Therapeutics where she led the company's scientific strategy and worked to build their immune-driven pipeline. Prior to joining Quell, she was Chief Scientific Officer at Gamida Cell, Ltd. and held senior leadership roles at Blue Rock Therapeutics, Syros Pharma, and Sanofi/Genzyme where she led immunology efforts from discovery through early clinical development to FDA approvals. Dr. Lodie completed postdoctoral work Boston Universi
Show less
Read more
Impact Snapshot
Event Time:
GMDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMDA alerts
High impacting Gamida Cell Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
GMDA
News
- Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial ResultsGlobeNewswire
- Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR® [Yahoo! Finance]Yahoo! Finance
- Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®GlobeNewswire
- Gamida Cell Ltd. (NASDAQ: GMDA) had its "market perform" rating re-affirmed by analysts at JMP Securities.MarketBeat
- Gamida Cell Actively Pursuing Strategic Alternatives [Yahoo! Finance]Yahoo! Finance
GMDA
Earnings
- 11/14/23 - Beat
GMDA
Sec Filings
- 4/5/24 - Form 8-K/A
- 4/1/24 - Form SC
- 3/29/24 - Form 8-K/A
- GMDA's page on the SEC website